| The SCARE 2020 guideline: updating consensus surgical CAse REport (SCARE) guidelines RA Agha, T Franchi, C Sohrabi, G Mathew, A Kerwan, A Thoma, ... International Journal of Surgery 84, 226-230, 2020 | 5432 | 2020 |
| MRI-targeted or standard biopsy for prostate-cancer diagnosis V Kasivisvanathan, AS Rannikko, M Borghi, V Panebianco, LA Mynderse, ... New England Journal of Medicine 378 (19), 1767-1777, 2018 | 2826 | 2018 |
| The SCARE statement: consensus-based surgical case report guidelines RA Agha, AJ Fowler, A Saeta, I Barai, S Rajmohan, DP Orgill, R Afifi, ... International journal of surgery 34, 180-186, 2016 | 1912 | 2016 |
| STROCSS 2021: strengthening the reporting of cohort, cross-sectional and case-control studies in surgery G Mathew, R Agha IJS Short Reports 6 (4), e35, 2021 | 1587 | 2021 |
| Standards of reporting for MRI-targeted biopsy studies (START) of the prostate: recommendations from an International Working Group CM Moore, V Kasivisvanathan, S Eggener, M Emberton, JJ Fütterer, ... European urology 64 (4), 544-552, 2013 | 468 | 2013 |
| Multiparametric MRI for prostate cancer diagnosis: current status and future directions A Stabile, F Giganti, AB Rosenkrantz, SS Taneja, G Villeirs, IS Gill, C Allen, ... Nature reviews urology 17 (1), 41-61, 2020 | 310 | 2020 |
| Preferred reporting of case series in surgery; the PROCESS guidelines RA Agha, AJ Fowler, S Rajmohan, I Barai, DP Orgill, R Afifi, R Alahmadi, ... International journal of surgery 36, 319-323, 2016 | 283 | 2016 |
| Elective cancer surgery in COVID-19–free surgical pathways during the SARS-CoV-2 pandemic: an international, multicenter, comparative cohort study JC Glasbey, D Nepogodiev, JFF Simoes, O Omar, E Li, ML Venn, PGDME, ... Journal of Clinical Oncology 39 (1), 66-78, 2021 | 261 | 2021 |
| Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study J Glasbey, A Ademuyiwa, A Adisa, E AlAmeer, AP Arnaud, F Ayasra, ... The Lancet Oncology 22 (11), 1507-1517, 2021 | 247 | 2021 |
| Reporting magnetic resonance imaging in men on active surveillance for prostate cancer: the PRECISE recommendations—a report of a European School of Oncology Task Force CM Moore, F Giganti, P Albertsen, C Allen, C Bangma, A Briganti, ... European urology 71 (4), 648-655, 2017 | 247 | 2017 |
| Negative predictive value of multiparametric magnetic resonance imaging in the detection of clinically significant prostate cancer in the prostate imaging reporting and data … NJ Sathianathen, A Omer, E Harriss, L Davies, V Kasivisvanathan, ... European urology 78 (3), 402-414, 2020 | 243 | 2020 |
| Transperineal magnetic resonance image targeted prostate biopsy versus transperineal template prostate biopsy in the detection of clinically significant prostate cancer V Kasivisvanathan, R Dufour, CM Moore, HU Ahmed, M Abd-Alazeez, ... The Journal of urology 189 (3), 860-866, 2013 | 227 | 2013 |
| Prostate Imaging Quality (PI-QUAL): a new quality control scoring system for multiparametric magnetic resonance imaging of the prostate from the PRECISION trial F Giganti, C Allen, M Emberton, CM Moore, V Kasivisvanathan, ... European urology oncology 3 (5), 615-619, 2020 | 207 | 2020 |
| Magnetic resonance imaging-targeted biopsy versus systematic biopsy in the detection of prostate cancer: a systematic review and meta-analysis V Kasivisvanathan, A Stabile, JB Neves, F Giganti, M Valerio, ... European urology 76 (3), 284-303, 2019 | 203 | 2019 |
| Delaying surgery for patients with a previous SARS-CoV-2 infection Journal of British Surgery 107 (12), e601-e602, 2020 | 144 | 2020 |
| Comparison of multiparametric magnetic resonance imaging–targeted biopsy with systematic transrectal ultrasonography biopsy for biopsy-naive men at risk for prostate cancer: a … L Klotz, J Chin, PC Black, A Finelli, M Anidjar, F Bladou, A Mercado, ... JAMA oncology 7 (4), 534-542, 2021 | 140 | 2021 |
| Factors influencing variability in the performance of multiparametric magnetic resonance imaging in detecting clinically significant prostate cancer: a systematic literature review A Stabile, F Giganti, V Kasivisvanathan, G Giannarini, CM Moore, ... European urology oncology 3 (2), 145-167, 2020 | 102 | 2020 |
| Preoperative nasopharyngeal swab testing and postoperative pulmonary complications in patients undergoing elective surgery during the SARS-CoV-2 pandemic British Journal of Surgery 108 (1), 88-96, 2021 | 95 | 2021 |
| Focal therapy for prostate cancer: rationale and treatment opportunities V Kasivisvanathan, M Emberton, HU Ahmed Clinical Oncology 25 (8), 461-473, 2013 | 72 | 2013 |
| Predictive factors of missed clinically significant prostate cancers in men with negative magnetic resonance imaging: a systematic review and meta-analysis MA Pagniez, V Kasivisvanathan, P Puech, E Drumez, A Villers, J Olivier Journal of Urology 204 (1), 24-32, 2020 | 71 | 2020 |
